ACOG committee opinion. Tamoxifen and the prevention of breast cancer in high-risk women. Number 224, October 1999. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists.
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D018570:Risk Assessment
D018931:Antineoplastic Agents, Hormonal